Controversy Around Suicidality Monitoring At Clinical Trials In Optimising Clinical Development In CNS, London, 15-16 March 2011
Links shared publicly online about this topic.
- 692total visits
Controversy Around Suicidality Monitoring At Clinical Trials In Optimising Clinical Development In CNS, London, 15-16 March 2011
The absence of suicidality monitoring in previous clinical trials has lead to a number of controversies beyond those surrounding Prozac. There has been continued discussion of a link between anti
View full resource at medicalnewstoday.com
Tags: Nervous System, Panic Disorder Medication, Obsessive-Compulsive Disorder Medication, PTSD Medication, Antidepressant, Clinical Trial, Prozac, Food and Drink
Most Recently Shared on November 29, 2010 at 4:05 pm By:
Controversy Around Suicidality Monitoring At Clinical Trials In Optimising Clinical Development In CNS, London, 15-16 ... http://mnt.to/3NcN
Also Shared By:
Advertisement
MNT Clinical Trials
@mnt_clinical
Controversy Around Suicidality Monitoring At Clinical Trials In Optimising Clinical Development In CNS, London, 15-16 ... http://mnt.to/3NcN
1 year ago...